10:37 AM EDT, 09/19/2024 (MT Newswires) -- Renovaro's ( RENB ) RenovaroCube unit and PersonalAIze said Thursday that they are collaborating to develop, validate and commercialize Cube's artificial intelligence platform for early detection of cancer and other diseases.

The partnership will provide services to artificial intelligence companies and healthcare systems, according to the companies.

Financial terms of the collaboration were not disclosed.

Shares of Renovaro ( RENB ) fell nearly 4% in recent trading.

Price: 0.52, Change: -0.02, Percent Change: -3.83